Market Overview

Benzinga's Top Upgrades

Share:
Related MYL
Biotech Stocks Convalescing After Wednesday's Trump-Inspired Biotech Selloff
Bernie Sanders' 'Trump Proposal' To Lower Drug Prices Blocked By Senate Republicans
Will Trump Break With Republicans And Push Major Drug Price Reform? (Investor's Business Daily)
Related SHLM
20 Biggest Mid-Day Gainers For Thursday
10 Notable Stocks Trading Ex-Dividend Thursday, October 20

Analysts at Canaccord upgraded Mylan (NASDAQ: MYL) from “hold” to “buy.” Mylan's shares closed at $25.00 yesterday. Mylan's trailing-twelve-month ROE is 15.70%.

Analysts at Longbow upgraded A. Schulman (NASDAQ: SHLM) from “underperform” to “neutral.” A. Schulman's shares closed at $25.14 yesterday. A. Schulman's PEG ratio is 0.79.

Analysts at Benchmark upgraded Expedia (NASDAQ: EXPE) from “hold” to “buy.” Expedia's stock closed at $51.25 yesterday. Expedia's trailing-twelve-month operating margin is 14.22%.

Analysts at RBC Capital upgraded PulteGroup (NYSE: PHM) from “sector perform” to “outperform.” PulteGroup's shares closed at $17.01 yesterday. PulteGroup's trailing-twelve-month revenue is $4.35 billion.

Latest Ratings for MYL

DateFirmActionFromTo
Oct 2016MizuhoInitiates Coverage OnBuy
Oct 2016Raymond JamesUpgradesMarket PerformStrong Buy
Sep 2016Leerink SwannMaintainsOutperform

View More Analyst Ratings for MYL
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (EXPE + MYL)

View Comments and Join the Discussion!